[ARCHIVE] Caldera Pharmaceuticals appoints Dr. Gary Altman to its Board of Directors as CEO
CAMBRIDGE, Mass. – Caldera Pharmaceuticals and its subsidiary XRpro Corp, a provider of proprietary drug discovery services for high-throughput ion-channel inhibitor assays and enzyme activity assays, announces that Gary G.…